Attività Cambiamento Data
Alterity Therapeutics Limited AUD 37.98M 15.78M 2025-12
Ardelyx USD 587.52M 11.63M 2026-09
aTyr Pharma USD 59.81M 10.02M 2026-09
Biogen USD 32.05B 32.5M 2026-09
Bristol-Myers Squibb USD 88.77B 1.14B 2026-09
Cipla INR 434.34B 9.38B 2026-09
Clal Biotechnology ILS 158.39M 24.3M 2023-12
Compugen USD 138.36M 7.5M 2026-06
CSL USD 37.9B 1.5B 2025-12
Curis USD 29.69M 9.72M 2026-03
GlaxoSmithKline GBP 71.7B 9.96B 2026-09
Grifols EUR 23.15B 142.7M 2025-12
Lakefront Biotherapeutics EUR 3.35B 21.24M 2026-06
Novartis USD 117.15B 4.88B 2026-09
Roche Holding CHF 98.2B 2.5B 2026-06
United Therapeutics USD 7.03B 186M 2026-09